Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement
22/07/2024 13:21
July 22 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O :
* PHARMA TWO B ANNOUNCES PLANS TO GO PUBLIC VIA MERGER WITH
HEPION
PHARMACEUTICALS, INC. AND CONCURRENT $11.5 MILLION PRIVATE
PLACEMENT
* HEPION PHARMACEUTICALS INC: CURRENT PHARMA TWO B
EQUITY-HOLDERS
WILL OWN ABOUT 85% OF COMBINED COMPANY
* HEPION PHARMACEUTICALS : CURRENT HEPION EQUITY-HOLDERS
WILL OWN
ABOUT 15% OF COMBINED COMPANY
* HEPION PHARMACEUTICALS- ENTERED PURCHASE DEAL WITH
INSTITUTIONAL
INVESTORS FOR SALE OF $2.9 MILLION SENIOR UNSECURED NOTE
* HEPION PHARMACEUTICALS INC: PROPOSED DEAL FOR $58.5
MILLION
Source text for Eikon: ID:nGNX9KQRwj
Further company coverage: HEPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement